Cargando…

Persistence of COVID-19 Symptoms after Recovery in Mexican Population

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must...

Descripción completa

Detalles Bibliográficos
Autores principales: Galván-Tejada, Carlos E., Herrera-García, Cintya Fabiola, Godina-González, Susana, Villagrana-Bañuelos, Karen E., Amaro, Juan Daniel De Luna, Herrera-García, Karla, Rodríguez-Quiñones, Carolina, Zanella-Calzada, Laura A., Ramírez-Barranco, Julio, de Avila, Jocelyn L. Ruiz, Reyes-Escobedo, Fuensanta, Celaya-Padilla, José M., Galván-Tejada, Jorge I., Gamboa-Rosales, Hamurabi, Martínez-Acuña, Mónica, Cervantes-Villagrana, Alberto, Rivas-Santiago, Bruno, Gonzalez-Curiel, Irma E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765113/
https://www.ncbi.nlm.nih.gov/pubmed/33327641
http://dx.doi.org/10.3390/ijerph17249367
_version_ 1783628415327272960
author Galván-Tejada, Carlos E.
Herrera-García, Cintya Fabiola
Godina-González, Susana
Villagrana-Bañuelos, Karen E.
Amaro, Juan Daniel De Luna
Herrera-García, Karla
Rodríguez-Quiñones, Carolina
Zanella-Calzada, Laura A.
Ramírez-Barranco, Julio
de Avila, Jocelyn L. Ruiz
Reyes-Escobedo, Fuensanta
Celaya-Padilla, José M.
Galván-Tejada, Jorge I.
Gamboa-Rosales, Hamurabi
Martínez-Acuña, Mónica
Cervantes-Villagrana, Alberto
Rivas-Santiago, Bruno
Gonzalez-Curiel, Irma E.
author_facet Galván-Tejada, Carlos E.
Herrera-García, Cintya Fabiola
Godina-González, Susana
Villagrana-Bañuelos, Karen E.
Amaro, Juan Daniel De Luna
Herrera-García, Karla
Rodríguez-Quiñones, Carolina
Zanella-Calzada, Laura A.
Ramírez-Barranco, Julio
de Avila, Jocelyn L. Ruiz
Reyes-Escobedo, Fuensanta
Celaya-Padilla, José M.
Galván-Tejada, Jorge I.
Gamboa-Rosales, Hamurabi
Martínez-Acuña, Mónica
Cervantes-Villagrana, Alberto
Rivas-Santiago, Bruno
Gonzalez-Curiel, Irma E.
author_sort Galván-Tejada, Carlos E.
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19.
format Online
Article
Text
id pubmed-7765113
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77651132020-12-27 Persistence of COVID-19 Symptoms after Recovery in Mexican Population Galván-Tejada, Carlos E. Herrera-García, Cintya Fabiola Godina-González, Susana Villagrana-Bañuelos, Karen E. Amaro, Juan Daniel De Luna Herrera-García, Karla Rodríguez-Quiñones, Carolina Zanella-Calzada, Laura A. Ramírez-Barranco, Julio de Avila, Jocelyn L. Ruiz Reyes-Escobedo, Fuensanta Celaya-Padilla, José M. Galván-Tejada, Jorge I. Gamboa-Rosales, Hamurabi Martínez-Acuña, Mónica Cervantes-Villagrana, Alberto Rivas-Santiago, Bruno Gonzalez-Curiel, Irma E. Int J Environ Res Public Health Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19. MDPI 2020-12-14 2020-12 /pmc/articles/PMC7765113/ /pubmed/33327641 http://dx.doi.org/10.3390/ijerph17249367 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Galván-Tejada, Carlos E.
Herrera-García, Cintya Fabiola
Godina-González, Susana
Villagrana-Bañuelos, Karen E.
Amaro, Juan Daniel De Luna
Herrera-García, Karla
Rodríguez-Quiñones, Carolina
Zanella-Calzada, Laura A.
Ramírez-Barranco, Julio
de Avila, Jocelyn L. Ruiz
Reyes-Escobedo, Fuensanta
Celaya-Padilla, José M.
Galván-Tejada, Jorge I.
Gamboa-Rosales, Hamurabi
Martínez-Acuña, Mónica
Cervantes-Villagrana, Alberto
Rivas-Santiago, Bruno
Gonzalez-Curiel, Irma E.
Persistence of COVID-19 Symptoms after Recovery in Mexican Population
title Persistence of COVID-19 Symptoms after Recovery in Mexican Population
title_full Persistence of COVID-19 Symptoms after Recovery in Mexican Population
title_fullStr Persistence of COVID-19 Symptoms after Recovery in Mexican Population
title_full_unstemmed Persistence of COVID-19 Symptoms after Recovery in Mexican Population
title_short Persistence of COVID-19 Symptoms after Recovery in Mexican Population
title_sort persistence of covid-19 symptoms after recovery in mexican population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765113/
https://www.ncbi.nlm.nih.gov/pubmed/33327641
http://dx.doi.org/10.3390/ijerph17249367
work_keys_str_mv AT galvantejadacarlose persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT herreragarciacintyafabiola persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT godinagonzalezsusana persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT villagranabanueloskarene persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT amarojuandanieldeluna persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT herreragarciakarla persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT rodriguezquinonescarolina persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT zanellacalzadalauraa persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT ramirezbarrancojulio persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT deavilajocelynlruiz persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT reyesescobedofuensanta persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT celayapadillajosem persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT galvantejadajorgei persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT gamboarosaleshamurabi persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT martinezacunamonica persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT cervantesvillagranaalberto persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT rivassantiagobruno persistenceofcovid19symptomsafterrecoveryinmexicanpopulation
AT gonzalezcurielirmae persistenceofcovid19symptomsafterrecoveryinmexicanpopulation